Cargando…

Molecular Therapeutic Advances in Personalized Therapy of Melanoma and Non-Small Cell Lung Cancer

The incorporation of individualized molecular therapeutics into routine clinical practice for both non-small cell lung cancer (NSCLC) and melanoma are amongst the most significant advances of the last decades in medical oncology. In NSCLC activating somatic mutations in exons encoding the tyrosine k...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kelleher, Fergal C., Solomon, Benjamin, McArthur, Grant A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251364/ https://www.ncbi.nlm.nih.gov/pubmed/25562798 http://dx.doi.org/10.3390/jpm2020035

Ejemplares similares

Novel combination therapies for BRAF-mutant melanoma
por: McArthur, Grant A
Publicado: (2015)

Targeting oncogenes in advanced melanoma
por: McArthur, GA
Publicado: (2012)

Combination Therapies to Inhibit the RAF/MEK/ERK Pathway in Melanoma: We are not Done Yet
por: McArthur, Grant A.
Publicado: (2015)

Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/primitive neuroectodermal tumours
por: Kelleher, Fergal C, et al.
Publicado: (2012)

The therapeutic potential of targeting minimal residual disease in melanoma
por: Patel, Riyaben P, et al.
Publicado: (2023)

Phenotype Switching in Melanoma: Implications for Progression and Therapy
por: Li, Frederic Zhentao, et al.
Publicado: (2015)

Metabolic Plasticity in Melanoma Progression and Response to Oncogene Targeted Therapies
por: Alkaraki, Arwa, et al.
Publicado: (2021)

BRAF-targeted therapy and immune responses to melanoma
por: Ngiow, Shin Foong, et al.
Publicado: (2013)

Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung Cancer
por: Kim, D. Nathan, et al.
Publicado: (2012)

Advances in molecular-based personalized non-small-cell lung cancer therapy: targeting epidermal growth factor receptor and mechanisms of resistance
por: Jotte, Robert M, et al.
Publicado: (2015)

Histologic and Genetic Advances in Refining the Diagnosis of “Undifferentiated Pleomorphic Sarcoma”
por: Kelleher, Fergal C., et al.
Publicado: (2013)

Zika Virus: Recent Advances towards the Development of Vaccines and Therapeutics
por: McArthur, Monica A.
Publicado: (2017)

BRAF inhibitor treatment of melanoma causing colonic polyps: An alternative hypothesis
por: Kelleher, Fergal C, et al.
Publicado: (2017)

Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics
por: Padinharayil, Hafiza, et al.
Publicado: (2022)

Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
por: Ascierto, Paolo A., et al.
Publicado: (2017)

Triplet Therapy in Melanoma — Combined BRAF/MEK Inhibitors and Anti-PD-(L)1 Antibodies
por: Dixon-Douglas, Julia R., et al.
Publicado: (2022)

Non-Small Cell Lung Cancer from Genomics to Therapeutics: A Framework for Community Practice Integration to Arrive at Personalized Therapy Strategies
por: Rajurkar, Swapnil, et al.
Publicado: (2020)

Emerging therapeutic agents for advanced non-small cell lung cancer
por: Chen, Ruqin, et al.
Publicado: (2020)

Therapeutic advances in non‐small cell lung cancer: Focus on clinical development of targeted therapy and immunotherapy
por: Cheng, Yuan, et al.
Publicado: (2021)

Personalizing Therapy with Targeted Agents in Non-Small Cell Lung Cancer
por: Dienstmann, Rodrigo, et al.
Publicado: (2011)

Surgery for Non-Small Cell Lung Cancer in the Personalized Therapy Era
por: Chiappetta, Marco, et al.
Publicado: (2023)

Non-small-cell lung cancer: molecular targeted therapy and personalized medicine – drug resistance, mechanisms, and strategies
por: Sechler, Marybeth, et al.
Publicado: (2013)

Immunomodulatory Effects of BRAF, MEK, and CDK4/6 Inhibitors: Implications for Combining Targeted Therapy and Immune Checkpoint Blockade for the Treatment of Melanoma
por: Lelliott, Emily J., et al.
Publicado: (2021)

Targeted therapies for advanced non-small cell lung cancer
por: Ai, Xiaojuan, et al.
Publicado: (2018)

Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing
por: Dong, Jingsi, et al.
Publicado: (2019)

Optimizing the management of advanced non-small-cell lung cancer: a personal view
por: Vincent, M.D.
Publicado: (2009)

Personalized treatment of advanced non-small-cell lung cancer in routine clinical practice
por: Pirker, Robert, et al.
Publicado: (2016)

Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized Medicine
por: Tabchi, Samer, et al.
Publicado: (2017)

Harnessing the immunotherapeutic potential of CDK4/6 inhibitors in melanoma: is timing everything?
por: Lelliott, Emily J., et al.
Publicado: (2022)

Therapeutic Advances of Rare ALK Fusions in Non-Small Cell Lung Cancer
por: Xiang, Yan, et al.
Publicado: (2022)

Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers
por: Russano, Marco, et al.
Publicado: (2023)

The evolution of combined molecular targeted therapies to advance the therapeutic efficacy in melanoma: a highlight of vemurafenib and cobimetinib
por: Medina, Theresa M, et al.
Publicado: (2016)

Interleukin-11: A Potential Biomarker and Molecular Therapeutic Target in Non-Small Cell Lung Cancer
por: Leung, Jason Hongting, et al.
Publicado: (2022)

Technological and Therapeutic Advances in Advanced Small Cell Lung Cancer
por: Lum, Caroline, et al.
Publicado: (2019)

Obesity and the Impact on Cutaneous Melanoma: Friend or Foe?
por: Smith, Lorey K., et al.
Publicado: (2020)

Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer
por: Li, Wenbin, et al.
Publicado: (2015)

Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
por: Vanni, Irene, et al.
Publicado: (2020)

Emerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer
por: Li, Shenduo, et al.
Publicado: (2023)

Advances in CAR T Cell Therapy for Non-Small Cell Lung Cancer
por: Ma, Hong Yun, et al.
Publicado: (2023)

Advances in Personalized Targeted Treatment of Metastatic Melanoma and Non-Invasive Tumor Monitoring
por: Klinac, Dragana, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kkf62fgnvptr3aqauqvkp9quev